Kristi K DiRocco (Kristi DiRocco)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Mesenchymal Stem Cells

Top Venues

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)
Michael Bogart, Gary Yat-Hung Leung, Anissa Cyhaniuk, Kristi K DiRocco
Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy. International journal of chronic obstructive pulmonary disease 19 (2024)
Michael Bogart, Gary Yat-Hung Leung, Anissa Cyhaniuk, Kristi K DiRocco
Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy. International journal of chronic obstructive pulmonary disease 19 (2024)
Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)